Tests a virtual reality headset for checking vision loss from glaucoma
Compares a virtual reality vision test with the standard test in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Key facts
- Where
- Halifax, CanadaSee the site
Where in Canada
- Eadie Technologies IncHalifax, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nova Scotia Health Authority
- Trial code
- NCT07063537
- Record updated
- 14 July 2025
- Original description
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are:Read full original descriptionShow less
Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients With Early, Moderate, and Advanced Glaucoma
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are:
* Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices?
Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Inclusion: >18 years of age; diagnosis of primary open-angle glaucoma; ability to perform visual field testing; capacity to provide informed consent to research protocol.
Exclusion: previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery); seizure disorder; cardiac pacemaker/other implantable device; severe vertigo/balance disorder; diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy; significant media opacity; pregnancy.